ReviewJournal of molecular neuroscience : MN2026
Peroxisome Proliferator-Activated Receptor Delta (PPARδ) as a Metabolic Gatekeeper of Cerebrovascular Integrity.
Review in Journal of molecular neuroscience : MN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The peroxisome proliferator-activated receptor delta (PPARδ) is a nuclear receptor highly expressed in vasculature and serves a central role in coordinating vascular and metabolic homeostasis across multiple physiological systems. Recent studies have highlighted PPARδ's remarkable ability to regulate endothelial fatty acid oxidation, enhance metabolic flexibility, and modulate angiogenic responses critical for vascular adaptation and repair. Beyond its metabolic functions, PPARδ orchestrates multiple protective pathways that preserve cerebrovascular homeostasis, including endothelial repair, maintenance of blood-brain barrier integrity, mitochondrial biogenesis, and stability of the neurovascular unit, collectively enhancing endothelial resilience to stress. Dysregulation of PPARδ signaling has been implicated in various vascular and neurodegenerative disease states, underscoring its clinical relevance. In this literature review, we synthesize current findings on PPARδ-mediated signaling pathways and evaluate its potential as a promising therapeutic target. We further explore mechanistic roles across pathological contexts, as well as discuss emerging translational strategies aimed at harnessing PPARδ modulation for vascular and neuroprotective therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.